VAIA
TNDM icon

Virtus Alternative Investment Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-52
Closed -$5K – 203
2020
Q4 		$5K Sell
52
-50
-49% -$5.15K 0.07% 267
2020
Q3 		$12K Sell
102
-66
-39% -$6.93K 0.22% 70
2020
Q2 		$17K Buy
+168
New +$13.4K 0.27% 94

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Virtus Alternative Investment Advisers's TNDM Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 52 shares — an estimated $5K sold.

Virtus Alternative Investment Advisers first reported a position in TNDM in Q2 2020 and held it in 3 quarters. The position peaked at $17K in Q2 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 52 Tandem Diabetes Care shares in Q1 2021, an estimated $5K.
  • Virtus Alternative Investment Advisers first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 3 quarters.
  • Virtus Alternative Investment Advisers's Tandem Diabetes Care position peaked at $17K in Q2 2020.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.